메뉴 건너뛰기




Volumn 187, Issue 2, 2017, Pages 213-224

RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis

Author keywords

M3 muscarinic acetylcholine receptor; ROR t antagonist; sialadenitis; Sj gren's syndrome

Indexed keywords

A 213; CELL NUCLEUS RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN P 15095; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 17; INTERLEUKIN 4; MITOMYCIN; MUSCARINIC RECEPTOR; PROTEIN INHIBITOR; RAG1 PROTEIN; RETINOIC ACID RECEPTOR RELATED ORPHAN RECEPTOR GAMMA T; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; A213 COMPOUND; AMINOPYRIDINE DERIVATIVE; ENZYME INHIBITOR; MUSCARINIC M3 RECEPTOR; PEPTIDE FRAGMENT; RETINOID RELATED ORPHAN RECEPTOR GAMMA; SULFONAMIDE;

EID: 84991109203     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12868     Document Type: Article
Times cited : (16)

References (38)
  • 2
    • 84863218864 scopus 로고    scopus 로고
    • Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry
    • Malladi AS, Sack KE, Shiboski SC et al. Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry. Arthritis Care Res (Hoboken) 2012; 64:911–8.
    • (2012) Arthritis Care Res (Hoboken) , vol.64 , pp. 911-918
    • Malladi, A.S.1    Sack, K.E.2    Shiboski, S.C.3
  • 4
    • 0344585384 scopus 로고    scopus 로고
    • Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice
    • Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171:6173–7.
    • (2003) J Immunol , vol.171 , pp. 6173-6177
    • Nakae, S.1    Nambu, A.2    Sudo, K.3    Iwakura, Y.4
  • 5
    • 66849099394 scopus 로고    scopus 로고
    • Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism
    • Jetten AM. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 2009; 7:e003.
    • (2009) Nucl Recept Signal , vol.7
    • Jetten, A.M.1
  • 6
    • 84919665375 scopus 로고    scopus 로고
    • A crucial role of RORγt in the development of spontaneous sialadenitis-like Sjögren's syndrome
    • Iizuka M, Tsuboi H, Matsuo N et al. A crucial role of RORγt in the development of spontaneous sialadenitis-like Sjögren's syndrome. J Immunol 2015; 194:56–67.
    • (2015) J Immunol , vol.194 , pp. 56-67
    • Iizuka, M.1    Tsuboi, H.2    Matsuo, N.3
  • 7
    • 37849048599 scopus 로고    scopus 로고
    • T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ
    • Yang XO, Pappu BP, Nurieva R et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ. Immunity 2008; 28:29–39.
    • (2008) Immunity , vol.28 , pp. 29-39
    • Yang, X.O.1    Pappu, B.P.2    Nurieva, R.3
  • 9
    • 39449101603 scopus 로고    scopus 로고
    • Transcriptional regulation of Th17 cell differentiation
    • Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007; 19:409–17.
    • (2007) Semin Immunol , vol.19 , pp. 409-417
    • Ivanov, I.I.1    Zhou, L.2    Littman, D.R.3
  • 10
    • 44049104564 scopus 로고    scopus 로고
    • The differentiation of human TH-17 cells requires transforming growth factor-b and induction of the nuclear receptor RORγt
    • Manel N, Unutmaz D, Littman DR. The differentiation of human TH-17 cells requires transforming growth factor-b and induction of the nuclear receptor RORγt. Nat Immunol 2008; 9:641–9.
    • (2008) Nat Immunol , vol.9 , pp. 641-649
    • Manel, N.1    Unutmaz, D.2    Littman, D.R.3
  • 11
    • 84923870123 scopus 로고    scopus 로고
    • ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes
    • Solt LA, Banerjee S, Campbell S, Kamenecka TM, Burris TP. ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes. Endocrinology 2015; 156:869–81.
    • (2015) Endocrinology , vol.156 , pp. 869-881
    • Solt, L.A.1    Banerjee, S.2    Campbell, S.3    Kamenecka, T.M.4    Burris, T.P.5
  • 12
    • 84896287211 scopus 로고    scopus 로고
    • Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model
    • Chang MR, Lyda B, Kamenecka TM, Griffin PR. Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model. Arthritis Rheumatol 2014; 66:579–88.
    • (2014) Arthritis Rheumatol , vol.66 , pp. 579-588
    • Chang, M.R.1    Lyda, B.2    Kamenecka, T.M.3    Griffin, P.R.4
  • 13
    • 77958150989 scopus 로고    scopus 로고
    • Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis
    • Iizuka M, Wakamatsu E, Tsuboi H et al. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis. J Autoimmun 2010; 35:383–9.
    • (2010) J Autoimmun , vol.35 , pp. 383-389
    • Iizuka, M.1    Wakamatsu, E.2    Tsuboi, H.3
  • 14
    • 33947602423 scopus 로고    scopus 로고
    • Regulation of salivary gland function by autonomic nerves
    • Proctor GB, Carpenter GH. Regulation of salivary gland function by autonomic nerves. Auton Neurosci 2007; 133:3–18.
    • (2007) Auton Neurosci , vol.133 , pp. 3-18
    • Proctor, G.B.1    Carpenter, G.H.2
  • 15
    • 14144251323 scopus 로고    scopus 로고
    • Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome
    • Naito Y, Matsumoto I, Wakamatsu E et al. Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome. Ann Rheum Dis 2005; 64:510–1.
    • (2005) Ann Rheum Dis , vol.64 , pp. 510-511
    • Naito, Y.1    Matsumoto, I.2    Wakamatsu, E.3
  • 16
    • 0035145180 scopus 로고    scopus 로고
    • Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren's syndrome
    • Bacman S, Berra A, Sterin-Borda L, Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren's syndrome. Invest Ophthalmol Vis Sci 2001; 42:321–7.
    • (2001) Invest Ophthalmol Vis Sci , vol.42 , pp. 321-327
    • Bacman, S.1    Berra, A.2    Sterin-Borda, L.3    Borda, E.4
  • 17
    • 37749048646 scopus 로고    scopus 로고
    • High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile onset Sjögren syndrome
    • Nakamura Y, Wakamatsu E, Matsumoto I et al. High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile onset Sjögren syndrome. Ann Rheum Dis 2008; 67:136–7.
    • (2008) Ann Rheum Dis , vol.67 , pp. 136-137
    • Nakamura, Y.1    Wakamatsu, E.2    Matsumoto, I.3
  • 18
    • 77956496706 scopus 로고    scopus 로고
    • New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome
    • Tsuboi H, Matsumoto I, Wakamatsu E et al. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome. Clin Exp Immunol 2010; 162:53–61.
    • (2010) Clin Exp Immunol , vol.162 , pp. 53-61
    • Tsuboi, H.1    Matsumoto, I.2    Wakamatsu, E.3
  • 19
    • 31144439287 scopus 로고    scopus 로고
    • Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren's syndrome
    • Naito Y, Matsumoto I, Wakamatsu E et al. Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren's syndrome. Ann Rheum Dis 2006; 65:269–71.
    • (2006) Ann Rheum Dis , vol.65 , pp. 269-271
    • Naito, Y.1    Matsumoto, I.2    Wakamatsu, E.3
  • 20
    • 84877773390 scopus 로고    scopus 로고
    • The crucial roles of IFN-γ in the development of M3 muscarinic acetylcholine receptor induced Sjögren's syndrome-like sialadenitis
    • Iizuka M, Tsuboi H, Matsuo N et al. The crucial roles of IFN-γ in the development of M3 muscarinic acetylcholine receptor induced Sjögren's syndrome-like sialadenitis. Mod Rheumatol 2013; 23:614–6.
    • (2013) Mod Rheumatol , vol.23 , pp. 614-616
    • Iizuka, M.1    Tsuboi, H.2    Matsuo, N.3
  • 21
    • 84983458530 scopus 로고    scopus 로고
    • M3 muscarinic acetylcholine receptor reactive IL-17 producing T cells promotes development of Sjögren's syndrome like sialadenitis
    • Iizuka M, Tsuboi H, Asashima H et al. M3 muscarinic acetylcholine receptor reactive IL-17 producing T cells promotes development of Sjögren's syndrome like sialadenitis. Mod Rheumatol 2015; 25:158–60.
    • (2015) Mod Rheumatol , vol.25 , pp. 158-160
    • Iizuka, M.1    Tsuboi, H.2    Asashima, H.3
  • 22
    • 0034662903 scopus 로고    scopus 로고
    • Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype
    • Matsui M, Motomura D, Karasawa H et al. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci U S A 2000; 97:9579–84.
    • (2000) Proc Natl Acad Sci U S A , vol.97 , pp. 9579-9584
    • Matsui, M.1    Motomura, D.2    Karasawa, H.3
  • 23
    • 78649539346 scopus 로고    scopus 로고
    • IFN-g and IL-12 synergize to convert in vivo generated Th17 into Th1 Th17 cells
    • Lexberg MH, Taubner A, Albrecht I et al. IFN-g and IL-12 synergize to convert in vivo generated Th17 into Th1 Th17 cells. Eur J Immunol 2010; 40:3017–27.
    • (2010) Eur J Immunol , vol.40 , pp. 3017-3027
    • Lexberg, M.H.1    Taubner, A.2    Albrecht, I.3
  • 24
    • 58149251898 scopus 로고    scopus 로고
    • Late developmental plasticity in the T helper 17 linage
    • Lee YK, Turner H, Maynard CL et al. Late developmental plasticity in the T helper 17 linage. Immunity 2009; 30:92–107.
    • (2009) Immunity , vol.30 , pp. 92-107
    • Lee, Y.K.1    Turner, H.2    Maynard, C.L.3
  • 25
    • 58149216715 scopus 로고    scopus 로고
    • Th memory for interleukin-17 expression is stable in vivo
    • Lexberg MH, Taubner A, Förster A et al. Th memory for interleukin-17 expression is stable in vivo. Eur J Immunol 2008; 38:2654–64.
    • (2008) Eur J Immunol , vol.38 , pp. 2654-2664
    • Lexberg, M.H.1    Taubner, A.2    Förster, A.3
  • 27
    • 84876777999 scopus 로고    scopus 로고
    • ILC1 populations join the border patrol
    • Maloy KJ, Uhlig HH. ILC1 populations join the border patrol. Immunity 2013; 38:630–2.
    • (2013) Immunity , vol.38 , pp. 630-632
    • Maloy, K.J.1    Uhlig, H.H.2
  • 28
    • 84898640432 scopus 로고    scopus 로고
    • Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages
    • Klose CS, Flach M, Möhle L et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 2014; 157:340–56.
    • (2014) Cell , vol.157 , pp. 340-356
    • Klose, C.S.1    Flach, M.2    Möhle, L.3
  • 29
    • 84876780238 scopus 로고    scopus 로고
    • Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells
    • Fuchs A, Vermi W, Lee JS et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity 2013; 38:769–81.
    • (2013) Immunity , vol.38 , pp. 769-781
    • Fuchs, A.1    Vermi, W.2    Lee, J.S.3
  • 30
  • 31
    • 84924370171 scopus 로고    scopus 로고
    • Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: rheumatoid arthritis with Orencia trial toward Sjögren's syndrome endocrinopathy (ROSE) trial-an open-label, one-year, prospective study –interim analysis of 32 patients for 24 weeks
    • Tsuboi H, Matsumoto I, Hagiwara S et al. Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: rheumatoid arthritis with Orencia trial toward Sjögren's syndrome endocrinopathy (ROSE) trial-an open-label, one-year, prospective study –interim analysis of 32 patients for 24 weeks. Mod Rheumatol 2015; 25:187–93.
    • (2015) Mod Rheumatol , vol.25 , pp. 187-193
    • Tsuboi, H.1    Matsumoto, I.2    Hagiwara, S.3
  • 32
    • 54349116244 scopus 로고    scopus 로고
    • Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomized, double-blind, placebo-controlled pilot study
    • Dass S, Bowman SJ, Vital EM et al. Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomized, double-blind, placebo-controlled pilot study. Ann Rheum Dis 2008; 67:1541–4.
    • (2008) Ann Rheum Dis , vol.67 , pp. 1541-1544
    • Dass, S.1    Bowman, S.J.2    Vital, E.M.3
  • 33
    • 84877611272 scopus 로고    scopus 로고
    • Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry
    • Gottenberg JE, Cinquetti G, Larroche C et al. Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis 2013; 72:1026–31.
    • (2013) Ann Rheum Dis , vol.72 , pp. 1026-1031
    • Gottenberg, J.E.1    Cinquetti, G.2    Larroche, C.3
  • 34
    • 84938686604 scopus 로고    scopus 로고
    • Efficacy and safety of rituximab in systemic lupus erythematosus and Sjogren syndrome patients with refractory thrombocytopenia: a retrospective study of 21 cases
    • Jiang B, Li T, Guo L, Shen H, Ye S, Chen S. Efficacy and safety of rituximab in systemic lupus erythematosus and Sjogren syndrome patients with refractory thrombocytopenia: a retrospective study of 21 cases. J Clin Rheumatol 2015; 23:244–50.
    • (2015) J Clin Rheumatol , vol.23 , pp. 244-250
    • Jiang, B.1    Li, T.2    Guo, L.3    Shen, H.4    Ye, S.5    Chen, S.6
  • 35
    • 84894243056 scopus 로고    scopus 로고
    • Treatment of primary Sjögren syndrome with rituximab: a randomized trial
    • Devauchelle-Pensec V, Mariette X, Jousse-Joulin S et al. Treatment of primary Sjögren syndrome with rituximab: a randomized trial. Ann Intern Med 2014; 160:233–42.
    • (2014) Ann Intern Med , vol.160 , pp. 233-242
    • Devauchelle-Pensec, V.1    Mariette, X.2    Jousse-Joulin, S.3
  • 36
    • 84906980128 scopus 로고    scopus 로고
    • Treatment of primary Sjögren syndrome with rituximab
    • Faustman DL, Vivino FB, Carsons SE. Treatment of primary Sjögren syndrome with rituximab. Ann Intern Med 2014; 161:376–7.
    • (2014) Ann Intern Med , vol.161 , pp. 376-377
    • Faustman, D.L.1    Vivino, F.B.2    Carsons, S.E.3
  • 37
    • 0023976470 scopus 로고
    • Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains
    • Einfeld DA, Brown JP, Valentine MA, Clark EA, Ledbetter JA. Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J 1988; 7:711–7.
    • (1988) EMBO J , vol.7 , pp. 711-717
    • Einfeld, D.A.1    Brown, J.P.2    Valentine, M.A.3    Clark, E.A.4    Ledbetter, J.A.5
  • 38
    • 0024410224 scopus 로고
    • Phosphorylation of the CD20 phosphoprotein in resting B lymphocytes. Regulation by protein kinase C
    • Valentine MA, Meier KE, Rossie S, Clark EA. Phosphorylation of the CD20 phosphoprotein in resting B lymphocytes. Regulation by protein kinase C. J Biol Chem 1989; 264:11282–7.
    • (1989) J Biol Chem , vol.264 , pp. 11282-11287
    • Valentine, M.A.1    Meier, K.E.2    Rossie, S.3    Clark, E.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.